MFAP5 and neoplasm: To further confirm involvement of CD8+T cells in MFAP5_KD subgroups, CD8 deletion assay was performed in vivo and the tumor volume in MFAP5 deficient subgroup was restored when CD8 + T cells were neutralized with anti-CD8 antibody (Figs. S9F, G).